Ninchoji Takeshi, Aoto Yuya, Momo Natsuki, Maruyama Jun, Ioi Hiroaki, Uchida Hayato
Department of Paediatrics, Harima Himeji General Medical Centre, Himeji, Japan.
Ioi Pediatrics Clinic, Himeji, Japan.
Front Pediatr. 2023 Aug 10;11:1228681. doi: 10.3389/fped.2023.1228681. eCollection 2023.
This study investigated the status of children with obesity before and after the COVID-19 pandemic, and the effects of lifestyle guidance on weight loss among children in Japan. We analysed the data of patients who visited our hospital after check-ups for obesity and evaluated the efficacy of lifestyle guidance. The patients were divided into groups A, B, and C (year 2011, 2019, and 2021, respectively). There were no differences in body weight, obesity index (OI), blood pressure, or alanine transaminase (ALT) levels between the groups; however, aspartate transaminase (AST) level was the highest in Group C. In Group C, only OI increased between the primary and secondary screenings; however, OI and body mass index (BMI) improved during the second screening and more children in the weight loss group followed lifestyle guidance. OI/BMI did not change over the past decade; however, short-term weight gain was significant owing to the COVID-19 pandemic, and simple guidance was effective in reducing weight. Future challenges include identifying methods to achieve long-term weight loss.
本研究调查了新冠疫情前后日本肥胖儿童的状况，以及生活方式指导对儿童体重减轻的影响。我们分析了因肥胖检查前来我院就诊的患者数据，并评估了生活方式指导的效果。患者被分为A、B、C组（分别对应2011年、2019年和2021年）。各组之间的体重、肥胖指数（OI）、血压或丙氨酸转氨酶（ALT）水平无差异；然而，C组的天冬氨酸转氨酶（AST）水平最高。在C组中，仅初次筛查和二次筛查之间OI有所增加；然而，二次筛查期间OI和体重指数（BMI）有所改善，且减肥组中更多儿童遵循了生活方式指导。过去十年间OI/BMI没有变化；然而，由于新冠疫情短期体重增加显著，简单的指导对减轻体重有效。未来的挑战包括确定实现长期体重减轻的方法。
